Drug Trial Radar · NCT01696110
BivaliRudin in Acute Myocardial Infarction vs Glycoprotein IIb/IIIa and Heparin :a Randomised Controlled Trial.
Last checked: Nov 20, 2026Latest source record: Oct 1, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,194
Actual
Start
Aug 2012
Primary completion
Jul 2013
Study completion Jul 2014
Sponsor
- Lead sponsor
- Shenyang Northern HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Sep 28, 2012
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study would enrolled a total of 2100 AMI patients undergoing PCI to one of three antithrombotic regimens: bivalirudin alone, or unfractionated heparin alone, or unfractionated heparin plus a glycoprotein IIb/IIIa inhibitor. All enrolled patients would be followed-up to 30 days, 6 months, and 1 year. The purpose of the study is to evaluate the efficacy and safety of bivalirudin in AMI patients with DES.
Conditions
- Acute Myocardial Infarction
- Percutaneous Coronary Intervention
Interventions
BivalirudinDrug
Patients would be given anticoagulant therapy with bivalirudin in acute myocardial infarction during emergency PCI operation.
heparinDrug
heparin monotherapy
heparin plus tirofibanDrug
combined use of heparin and tirofiban during PCI
Primary outcomes
What the sponsor says the trial is designed to measure.
- Net Adverse Clinical EventsTime frame: 30 days
Locations
81 sites in 1 country. Site status is shown where the registry gives one.
1 st Hosp. of Anhui Med Univ.
Hefei, Anhui, China
Anhui Provincial Hosp.
Hefei, Anhui, China
3rd Hosp. of Beijing Univ.
Beijing, Beijing Municipality, China
Beijing Anzhen Hosp.
Beijing, Beijing Municipality, China
Beijing CAPF General Hosp.
Beijing, Beijing Municipality, China
Beijing Chaoyang Hosp.
Beijing, Beijing Municipality, China
Beijing Friendship Hosp.
Beijing, Beijing Municipality, China
Beijing General Hosp. of PLA
Beijing, Beijing Municipality, China
Beijing Hosp.
Beijing, Beijing Municipality, China
Beijing Luhe Hosp.
Beijing, Beijing Municipality, China
General Hosp of PLA (1)
Beijing, Beijing Municipality, China
General Hosp. of PLA(2)
Beijing, Beijing Municipality, China
Navy General Hosp. of PLA
Beijing, Beijing Municipality, China
No.304 Hosp. of PLA
Beijing, Beijing Municipality, China
No.306 Hosp. of PLA
Beijing, Beijing Municipality, China
Peking Univ. First Hosp.
Beijing, Beijing Municipality, China
The 2nd artillery general Hosp. of PLA
Beijing, Beijing Municipality, China
Chongqing Daping Hosp.
Chongqing, Chongqing Municipality, China
Fujian Med Univ. Uion Hosp.
Fuzhou, Fujian, China
1 st Hosp. of Lanzhou Univ.
Lanzhou, Gansu, China
Lanzhou General Hosp. of PLA
Lanzhou, Gansu, China
1 st Hosp. of Guangzhou MU
Guangzhou, Guangdong, China
1st Hosp. of Zhongshan MU
Guangzhou, Guangdong, China
Guangdong General Hosp.
Guangzhou, Guangdong, China
Guangzhou General Hosp. of PLA
Guangzhou, Guangdong, China
1 st Hosp. of Guangxi Med Univ.
Nanning, Guangxi, China
No.252 Hosp. of PLA
Baoding, Hebei, China
Cangzhou Centeral Hosp.
Cangzhou, Hebei, China
Qinhuangdao No.1 Hosp.
Qinhuangdao, Hebei, China
Hebei General Hosp.
Shijiazhuang, Hebei, China
Shijiazhuang Peace Hosp.
Shijiazhuang, Hebei, China
Tangshan Gongren Hosp.
Tangshan, Hebei, China
Daqing General Hosp. of OF.
Daqing, Heilongjiang, China
No.152 Hosp.
Pingdingshan, Henan, China
Wuhan Asican Heart Hosp.
Wuhan, Hubei, China
Wuhan General Hosp of PLA
Wuhan, Hubei, China
Nanjing First Hosp.
Nanjing, Jiangsu, China
Xuzhou Med Col. Affiliated Hosp.
Xuzhou, Jiangsu, China
Xuzhou No.4 Hosp.
Xuzhou, Jiangsu, China
2 nd Hosp. of Nanchang Univ.
Nanchang, Jiangxi, China
Showing 40 of 81 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.